Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

ByScott D. Ramsey, MD, PhD,Gary H. Lyman, MD, MPH

April 16th 2015

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

BySuja S. Rajan, MHA, MS, PhD,William R. Carpenter, MHA, PhD,Sally C. Stearns, PhD,Gary H. Lyman, MD, MPH

February 13th 2013

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.

Latest Updated Articles

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
April 16th 2015
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
February 13th 2013

Gary H. Lyman, MD, MPH

Articles by Gary H. Lyman, MD, MPH

Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Latest Updated Articles

Trending on AJMC

FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC

ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs

5 Things to Know About Diabetes-Related Eye Disease Awareness Month

Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic

High FLT3-ITD Allelic Ratio Not Tied to Worse OS in AML in BIG-1 Data